Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

被引：44
|
作者：
Zhao, Jing [1 ]
Tostivint, Isabelle [2 ,3 ]
Xu, Lingdong [1 ]
Huang, Jihan [4 ]
Gambotti, Laetitia [5 ]
Boffa, Jean-Jacques [3 ,6 ]
Yang, Min [7 ]
Wang, Ling [8 ]
Sun, Zhuxing [9 ]
Chen, Xiaolan [10 ]
Liou-Schischmanoff, Amelie [3 ,11 ]
Baumelou, Alain [2 ,3 ]
Ma, Teng [12 ]
Lu, Guoyuan [13 ]
Li, Ling [14 ]
Chen, Dai [15 ]
Pieroni, Laurence [16 ]
Liu, Bingkai [3 ]
Qin, Xiao [1 ]
He, Weiming [1 ]
Wang, Yuejuan [1 ]
Gu, Harvest F. [17 ]
Sun, Wei [1 ]
机构：
[1] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China
[2] Sorbonne Univ, Pitie Salpetriere Hosp, Dept Nephrol, Paris, France
[3] Sorbonne Univ, Pitie Salpetriere Hosp, Ctr Integrat Chinese Med, Paris, France
[4] Shanghai Univ Tradit Chinese Med, Ctr Drug Clin Res, Shanghai, Peoples R China
[5] Natl Canc Inst, Dept Clin Res, Boulogne, France
[6] Sorbonne Univ, Hosp Tenon, Dept Nephrol, Paris, France
[7] First Peoples Hosp Changzhou, Dept Nephrol, Changzhou, Peoples R China
[8] First Peoples Hosp Xuzhou, Dept Nephrol, Xuzhou, Peoples R China
[9] Wuxi Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China
[10] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Peoples R China
[11] Sorbonne Univ, Dept Pharm, Pitie Salpetriere, Paris, France
[12] Taizhou Hosp Tradit Chinese Med, Dept Nephrol, Taizhou, Peoples R China
[13] Soochow Univ, Dept Nephrol, Affiliated Hosp 1, Suzhou, Peoples R China
[14] Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Peoples R China
[15] Changzhou Hosp Tradit Chinese Med, Dept Nephrol, Changzhou, Peoples R China
[16] Sorbonne Univ, Hosp Tenon, Dept Biochem Hormonol, Paris, France
[17] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China
来源：
DIABETES CARE | 2022年 / 45卷 / 07期
关键词：
NEPHROPATHY;
D O I：
10.2337/dc22-0607
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E113 / E115
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Jang, Hak Chul
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yong Soo
    Kim, Sang Jin
    Choi, Dong Seop
    PLOS ONE, 2014, 9 (04):
  • [22] Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial (vol 60, pg 1685, 2023)
    Tavakolizadeh, Mahdi
    Peyrovi, Saeid
    Ghasemi-Moghaddam, Hussein
    Bahadori, Ali
    Mohkami, Zeynab
    Sotoudeh, Mahtab
    Ziaee, Mojtaba
    ACTA DIABETOLOGICA, 2023, 60 (12) : 1697 - 1697
  • [23] Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease
    Hanrahan, John P.
    de Boer, Ian
    Bakris, George
    Wilson, Phebe
    Wakefield, James D.
    Seferovic, Jelena P.
    Chickering, Jennifer
    Cressman, Michael
    Currie, Mark
    Milne, George T.
    Profy, Albert T.
    DIABETES, 2020, 69
  • [24] Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
    Li, Ping
    Chen, Yiping
    Liu, Jianping
    Hong, Jing
    Deng, Yueyi
    Yang, Fang
    Jin, Xiuping
    Gao, Jing
    Li, Jing
    Fang, Hui
    Liu, Geling
    Shi, Liping
    Du, Jinhang
    Li, Yang
    Yan, Meihua
    Wen, Yumin
    Yang, Wenying
    PLOS ONE, 2015, 10 (05):
  • [25] Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
    Barzilai, Nir
    Guo, Hua
    Mahoney, Erin M.
    Caporossi, Suzanne
    Golm, Gregory T.
    Langdon, Ronald B.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Amatruda, John M.
    Goldstein, Barry J.
    Steinberg, Helmut
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 1049 - 1058
  • [26] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Zhang, Bo
    Cheng, Zhifeng
    Chen, Ji
    Zhang, Xin
    Liu, Dexue
    Jiang, Hongwei
    Ma, Guoqing
    Wang, Xiaoyun
    Gan, Shenglian
    Sun, Juan
    Jin, Ping
    Yi, Jianjun
    Shi, Bimin
    Ma, Jianhua
    Ye, Shandong
    Wang, Guixia
    Ji, Linong
    Gu, Xuejiang
    Yu, Ting
    An, Pei
    Deng, Huan
    Li, Haoyu
    Li, Li
    Ma, Qingyang
    Qian, Lei
    Yang, Wenying
    DIABETES CARE, 2024, 47 (01) : 160 - 168
  • [27] Creatine in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Gualano, Bruno
    Painneli, Vitor De Salles
    Roschel, Hamilton
    Artioli, Guilherme Giannini
    Neves, Manoel, Jr.
    De Sa Pinto, Ana Lucia
    Rossi Da Silva, Maria Elizabeth
    Cunha, Maria Rosaria
    Garcia Otaduy, Maria Concepcion
    Leite, Claudia Da Costa
    Ferreira, Julio Cesar
    Pereira, Rosa Maria
    Brum, Patricia Chakur
    Bonfa, Eloisa
    Lancha, Antonio Herbert, Jr.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (05): : 770 - 778
  • [28] Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
    Apperloo, Ellen M.
    Gorriz, Jose L.
    Soler, Maria Jose
    Guldris, Secundino Cigarran
    Cruzado, Josep M.
    Puchades, Maria Jesus
    Lopez-Martinez, Marina
    Waanders, Femke
    Laverman, Gozewijn D.
    van der Aart-van der Beek, Annemarie
    Hoogenberg, Klaas
    van Beek, Andre P.
    Verhave, Jacobien
    Ahmed, Sofia B.
    Schmieder, Roland E.
    Wanner, Christoph
    Cherney, David Z. I.
    Jongs, Niels
    Heerspink, Hiddo J. L.
    NATURE MEDICINE, 2025, 31 (01) : 278 - 285
  • [29] Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
    Park, Ji-Yeon
    Lee, Joonyub
    Choi, Yoon-Hee
    Min, Wan
    Han, Kyung Ah
    Ahn, Kyu Jeung
    Lim, Soo
    Kim, Young-Hyun
    Ahn, Chul Woo
    Choi, Kyung Mook
    Yoon, Kun-Ho
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [30] Efficacy of Co-administration of Liuwei Dihuang Pills and Ginkgo Biloba Tablets on Albuminuria in Type 2 Diabetes: A 24-Month, Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Shi, Ruifeng
    Wang, Yanping
    An, Xiaofei
    Ma, Jianhua
    Wu, Tongzhi
    Yu, Xiaojin
    Liu, Su
    Huang, Liji
    Wang, Lijuan
    Liu, Jingshun
    Ge, Jing
    Qiu, Shanhu
    Yin, Han
    Wang, Xiaolai
    Wang, Yao
    Yang, Bingquan
    Yu, Jiangyi
    Sun, Zilin
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
12345